The sleep disorders;Disturbios do sono

Revista Brasileira de Medicina

Volumn 54, Issue 1-2, 1997, Pages 12-30

  Tufik, Sérgio ^a   Nery, Luís Eduardo ^a   Bittencourt, Lia Rita A ^a   Palombini, Luciana ^a   Bagnato, Maurício C ^a   Moura, Sônia Maria T ^a   Poyares, Dalva L R ^a   Pinto, Luciano R ^a   Remesar Lopez, Alberto J ^a   De Mello, Marco Túlio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; ACETAZOLAMIDE; ALMITRINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BROMOCRIPTINE; CLOMIPRAMINE; CLONAZEPAM; CLONIDINE; FLUOXETINE; IMIPRAMINE; LEVODOPA; MEDROXYPROGESTERONE ACETATE; METHYLPHENIDATE; NICOTINE; NITRAZEPAM; PEMOLINE; PROTRIPTYLINE; PSYCHOTROPIC AGENT; TEMAZEPAM;

APNEA; BRUXISM; HUMAN; INSOMNIA; NARCOLEPSY; PSYCHOSIS; REM SLEEP; REVIEW; SLEEP DISORDER;

EID: 8244248456     PISSN: 00347264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. The International Classification of Sleep Disorders - Diagnostic and Coding Manual. American Sleep Disorders Association, 1990.
2. Mendelson, B. W.: The search for the hypnogenic center. Prog. Neuro-Psychopharmacol and Biol. Psychiat., 14: 11-12, 1990.
3. Bootzin R. R.; Nicassio P.M.:Behavioral treatments in insomnia. Progress in behavior modification. New York: Academic Press, 6: 1-45, 1978.
4. Poyares D. L. R.; Lobo L.; Tufik S.: The consumption and alertness drugs in a population that complains of sleep disorders in Sāo Paulo. J Sleep Res. 5(suppl.1), 183, 1996. Apresentado no 13th Congress of the European Sleep Research Society, Bruxelas, Bélgica, 1996.
5. Hauri P. J. ; Olmested E. : Childhood onset insomnia. Sleep 3(1): 59-65, 1980.
6. Lugaresi E.; Medori R.; Montagna P.; et al. :Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N. Engl. J. Med., 315: 997-1003, 1986.
7. Moldofsky, H.; Scarisbrisck P.; England, R.; Smythe, H.: Musculoskeletal symptons and non-REM sleep disturbances in patients with "fibrositis syndrome" and health subjects. Psychosom. Med., 37: 341-351, 1975.
8. Poyares D.; Tufik S.: The effects of benzodiazepine replacement with Valerian in the sleep of patients with persistent insomnia: a preliminary study. Sleep Research 24A, 358, 1995. Apresentado no II International Congress, World Federation of Sleep Research Societes, Nassau, Bahamas, 1995.
9. Spielman A. S.; Saskin P.; Thorpy M.J. : Treatment of chronic insomnia by restriction of time in bed. Sleep, 10(1): 45-56, 1987.
10. Morin C.M.; Blais F. C.; Mineault V : Changes in beliefs and attitudes about sleep among insomnia patients treated with cognitive-behavior therapy and pharmacotherapy. Sleep Research 25, 1996.
11. Bootzin R. R. A stimulus control treatment for insomnia. Proceedings of American Psychological Association. 395-396, 1972.
12. Pack A. Obstructive sleep apnea. Adv. Int. Med., 39: 517-567, 1994.
13. Yong T., Palta M. et al. The ocurence of sleep disorders breathing among middle-age adults. N. Engl. J. Med.,328: 1230-1235, 1993.
14. He J., Kryger M.H., Zorick F.J. et al. :Mortality and apnea index in obstructive sleep apne: experience in 385 male patients. Chest , 94: 9-14, 1988.
15. Phillipson E. A. : Sleep apnea- a major public health problem(editorial). N. Engl. J. Med.,328: 1271-1273, 1993.
16. Guilleminault C., Stoohs R., Clerk A. et al. : From obstructive sleep apnea syndrome to upper airway resistance syndrome : consistency of daytime sleepness. Sleep, 15: 513-516, 1992.
17. Schwab R. I., Gupta K.B., Gefter WB et al.: Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disorders breathing: significance of lateral pharyngeal walls. Am J Respir. Crit. Care Med. 152: 167-189, 1995.
18. Issa F.G., Sullivan C.E.: Alcool: snoring and sleep apnea. J. Neurol. Neurosurgt. Psychiatry, 45: 353-359, 1992.
19. Rajagopal K.R., Abbrecht P.H., Derderian S.S. et al.: Obstructive sleep apnea in hypothyroidism. Ann. Intern. Med., 101:491, 1984.
20. Robinson R.W. and Zwillich C W.: The effect of drugs on breathing during sleep. Clinics in Chest Medicine. 6(4): 603-614, 1985.
21. Kryeger M.H.: Management of obstructive sleep apnea. Clin. Chest Med.13: 481-492, 1992.
22. Schmid-Nowara W., Lowe A., wiegeand L. et al. Oral appliance for the treatment of snoring and obstructive sleep apnea: a review. Sleep, 18(6): 501-510.
23. American Sleep Disorders Association Report. Practice parameters for treatment of obstructive sleep apnea in adults: the efficacy of surgical modifications of upper airway. Sleep, 19(2): 152-155, 1996.
24. Sher A. E., Schetman K. B., Piccirillo J.F. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep, 19(2): 156-177.
25. Riley R.W., Powell N., Guilleminault C.: Obstructive sleep apnea syndrome: a review of 306 consecutively surgical patients. Otolaryngol. Head Neck Surg. 108(2): 117-125, 1993.
26. Fujita S. Midline laser glossectomy with linguoplasty: a treatment of sleep apnea syndrome. Op. Tech. Otolaryngol. HNS, 2:127-131, 1991.
27. Montplaisir J., Godbout R., Pelletier G., Wames H.: Restless legs syndrome and periodic limb movements during sleep. Principles and practice of sleep medicine. W.B. Saunders Company, Philadelphia : 589. Second edition, 1994, 589-597.
28. Bixler E. O., Kales A., Vela-Bueno A. et al.: Noturnal myclonus and noturnal myoclonic activity in normal population. Res., Commun. Chem. Pathol. Pharmacol. 36: 129-140, 1982.
29. Bannerman C., Sleep disorders in later years. Postgrad. Med J., 84: 265-274, 1988.
30. Heiman E. M., Christie M.: lithium-aggravated nocturnal myoclonus and restless legs syndrome (letter). Am. J. psychiatry. 143: 1191-1192, 1986.
31. Ware J. C., Brown F. W., Moorad P.J. et al.: Nocturnal myoclonus and tricyclic antidepressants. Sleep Res., 13: 72, 1984.
32. Mello M. T., Mello F. A. A., Silva A. C. and Tufik S. : Incidence of periodic leg movements and of the restless legs syndrome during sleep following acute physycal activity in spinal cord injury subjects. Spinal cord., 34: 294-296
33. Guilleminault, C. Narcolepsy syndrome. In Kruger, M. H. Roth, T. & Dement, W.C., eds-Principles and Practice of Sleep Medicine. W. B. Sounders Company, Philadelphia, 1994,p. 549-561.
34. Sjöholm, T.; Lehtinen, I.; Helenius, H. Masseter muscle activity in diagnosed sleep bruxists compared with non-symptomatic controls. J. Sleep Res., 4(1): 48-55, 1995.
35. Lavigne, G. J.; Montplaisir, J. V. Bruxismepidemiology, diagnosis, Pathophysiology, and pharmacology. In: Fricton, J. R.; Dubner, R. Orofacial Pain and Temporomendibular Disorders. Raven Press, New York, Cap. 23: 387-404, 1995.
36. Satoh, T., Harada, Y. Electrophysiological study on tooth-grinding sleep. Electroencephalogr. Clin. Neurophysiol, 35: 267-75, 1973.
37. Uhde T. W. The Anxiety Disorders. Principles and Practice of Sleep Medicine. W. B. Sounders Company, Philadelphia, 1994, p.871-899.
38. Benca R. M.: Mood Disorders. Principles ans Practice of Sleep Medicine. W. B., Sounders Company, Philadelphia, 1994, p. 899-914.
39. Zarcone V. P., Benson K. L.: Sleep and Schizophrenia. Principles and Practice of Sleep Disorders, Sounders Company, Philadelphia, 1994, p.914-927.